It has indeed been proposed by some authors that the therapeutic use of BDNF itself or of drugs targeting its production may constitute a valid alternative to treat depressed patients with cognitive impairment or AD concomitant with depression [246]. The gene discussed is BDNF; the disease is depressive symptom measurement.